TRIKAFTA
Identification of Trikafta
| No description |
Google image searchProduct monograph
Active ingredients
tezacaftor, 25 MG
ivacaftor, 37.5 MG
ivacaftor, 75 MG
elexacaftor, 50 MG
DIN: 02526670
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Date: 22-APR-2022
ATC:
- R07 — OTHER RESPIRATORY SYSTEM PRODUCTS (ATC, ATC/DDD, )
- R07A — OTHER RESPIRATORY SYSTEM PRODUCTS (ATC, ATC/DDD)
- R07AX — Other respiratory system products (ATC, ATC/DDD)
- R07AX32 — IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR (ATC/DDD)
